Healthcare

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company…

9 months ago

Mobile-health Network Solutions Announces Closing of Initial Public Offering

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (“MNDR” or “the Company”), a leading telehealth solutions provider in…

9 months ago

Biomerica Reports Third Quarter 2024 Financial Results

Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the…

9 months ago

Ontario Psychological Association Unveils New Mental Health Insights – Report

TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- The Ontario Psychological Association (OPA) today released a pivotal report, “Mental Health in…

9 months ago

Intermountain McKay Dee Hospital and Intermountain Medical Center Named to Fortune’s 2024 Top 50 Heart Hospitals List

Fortune's 2024 Top 50 Heart Hospitals List Two Intermountain Health hospitals recognized as Fortune's 2024 Top 50 Heart Hospitals SALT…

9 months ago

Orpyx to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Orpyx, a med tech + touch company dedicated to transforming diabetic limb…

9 months ago

Teladoc Health to Announce First Quarter 2024 Financial Results

PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,…

9 months ago

Notable Labs Reports 2023 Financial Results and Provides a Business Update

FOSTER CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage…

9 months ago

Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets

MALVERN, Pa., April 12, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused…

9 months ago

Invivyd Announces CEO Transition

Jeremy Gowler appointed Interim CEOWALTHAM, Mass., April 12, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on…

9 months ago